Why are the Lipid-Soluble Antioxidants important to health and in preventive medicine?
More than 150 epidemiological studies have established inverse correlations between serum levels of carotenoids, tocopherols and retinol and the incidence of various cancers and other diseases in humans.1,2 Accurate determination of these analytes is a critical component of any prospective or retrospective study designed to evaluate the causal relationship between disease and the nutritional status of individuals.
Dietary carotenoids, tocopherols, retinol and CoQ10 have an impact on health and are associated with reduced risk of developing various cancers and other diseases.
Carotenoids |
Tocopherols |
Retinol |
Co Q10 |
Cancers sites associated with low intakes: |
|||
mouth 3 |
GI tract 9 |
lung 13 |
|
pharynx 4, 5 |
stomach 10 |
skin 14 |
|
larynx 4, 5 |
colon 10 |
bladder 15 |
|
esophagus 4, 5 |
mouth 11 |
prostate 16 |
|
stomach 5 |
pharynx 11 |
cervix 7 |
|
lung 6 |
reproductive organs 12 |
breast 8 |
|
cervix 7 |
cervix 7 |
mouth 3 |
|
breast 8 |
breast 8 |
lung13 |
|
Other diseases associated with low intakes: |
|||
cataracts 17 |
heart disease 19-21 |
blindness 14 |
LDL oxidatin 57-59 |
age-related macular degeneration 18, 23 |
cataracts 17, 22 |
night blindness 14 |
|
|
age-related macular degeneration |
infection 14 |
|
|
|
retarded growth |
|
|
|
abnormal embryonic development 14 |
|
Note: Genox’s
Products are for RESEARCH USE ONLY.
Users of Genox’s products are strongly advised NOT TO USE THEM
FOR CLINICAL/DIAGNOSTIC APPLICATIONS.
The provision of test reports, generated
by using Genox's products, to individuals
or to treating physicians for the diagnosis, prevention, treatment
and control of any human disease or impairment of, or the assessment
of the health, nutritional, or medical condition of individuals is
expressly prohibited by law. 42 U.S.C. § 263a
(2006); 42 C.F.R. § 493.3 (2006); COMAR 10.10.01.02 (2006). Genox
is not a CLIA certified laboratory.
© Copyright 1996-2010 Genox Corporation. All rights reserved.

